GlassScriptPhysician profile
John M Jennings
NPI 1386856243
$14,784.75
in general payments reported to CMS, 2019-2025
29 companies · $1,437 in 2025
The $1,437 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,288 · 2020: $1,352 · 2021: $6,123 · 2022: $1,583 · 2023: $1,115 · 2024: $887 · 2025: $1,437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,438.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,520.38 | 2019-2025 | Resonate El Icd Vr, Farapulse, Rhythmia Mapping System |
| Janssen Pharmaceuticals, INC | $3,762.52 | 2019-2024 | Xarelto |
| Abbott Laboratories | $2,265.63 | 2019-2025 | Accent, Ensite, Tacticath Ablation Catheter, Sensor Enabled |
| Novartis Pharmaceuticals Corporation | $1,018.99 | 2019-2023 | |
| Biosense Webster, INC. | $413.78 | 2019-2025 | Carto 3 |
| Amgen INC. | $389.33 | 2019-2025 | Repatha, Repatha |
| Medtronic, INC. | $363.03 | 2021-2024 | Pulseselect, Affera Mapping System, Arctic Front Advance |
| Medtronic Vascular, INC. | $332.37 | 2019 | |
| Pfizer INC. | $319.49 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $249.16 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $188.65 | 2019-2024 | Jardiance |
| Philips North America LLC | $124.01 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $107.54 | 2019-2025 | Evkeeza |
| Merck Sharp & Dohme LLC | $94.62 | 2023-2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $90.51 | 2022-2025 | Lifevest |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $81.83 | 2019-2024 | Wainua |
| Abiomed | $77.49 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $74.08 | 2019-2025 | Eliquis |
| Novo Nordisk INC | $41.40 | 2025 | Wegovy |
| Otsuka America Pharmaceutical, INC. | $38.91 | 2019 | |
| Cardiva Medical, INC. | $36.88 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| United Therapeutics Corporation | $33.45 | 2024 | Tyvaso |
| Convatec INC. | $30.57 | 2025 | |
| Alnylam Pharmaceuticals INC. | $29.91 | 2025 | Amvuttra |
| Atricure, INC. | $24.27 | 2024 | |
| Inspire Medical Systems, INC. | $20.92 | 2024 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $20.82 | 2021 | |
| Elutia, INC. | $17.45 | 2025 | Ecm Patch,Pouch |
| Idorsia Pharmaceuticals US INC | $16.76 | 2024 | Tryvio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Jennings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.